Imposing European-style price controls on prescription drugs in the United States would result in modest cost savings that would be more than offset by shortened life spans as the pace of drug innovation slows.
A Reuters article continues:
“We found policies that regulate the prices of drugs could result in modest savings for consumers, in the best [...]
Filed under: Uncategorized | Tagged: drug pricing, drug regulation, Innovation | Leave a Comment »
Dr. Kristina M. Lybecker
The safety and efficacy of medicines is something that most patients in developed countries take for granted. Whether it’s a vaccination, prescription, or over the counter drug, most people assume that the medicines they’re getting are legitimate. While bogus drugs are most frequently found in the most vulnerable markets – those of [...]
Filed under: Counterfeit drugs, Public health | Tagged: access to medicines, Counterfeit drugs, counterfeit medicines, patient safety, World Health Assembly | Leave a Comment »
What are the real access barriers to healthcare for people in Sub-Saharan Africa? The following article from the Wall Street Journal Europe provides an interesting perspective on the healthcare challenges in Nigeria, with a focus on AIDS patients. Mr. Ayodele states that the “real causes of restricted access to to AIDS drugs are Africa’s derelict transportation [...]
Filed under: Africa, Public health, intellectual property | Tagged: access to medicines, Africa, AIDS, Counterfeit drugs, patents, patient safety | Leave a Comment »
